# Delivery Order #SPE2D326F150H

Pfizer Delivery Order for Cyklokapron Injectable Medication

**Buyer:** Defense Logistics Agency

**Award Amount:** $179.68
**Ceiling:** $179.68

**Awarded:** May 27, 2026
**Period of Performance:** May 27, 2026 - May 28, 2026

**Identifier:** SPE2D326F150H
**NAICS:** 325412

This is a pharmaceutical delivery order issued to Pfizer Inc., a supplier of medicines, under the parent indefinite-delivery contract for pharmaceutical products. It covers Cyklokapron (tranexamic acid), supplied as 1,000 mg in a 10 mL vial, for delivery in New York. The order supports access to injectable medication through the Defense Logistics Agency’s broader military pharmaceutical supply arrangement. The parent contract was described as competitively awarded; the data does not specify the competition method for this individual order. The delivery order has a very short performance period, running from late May 2026 through the following day. No acquisition program, subcontractors, previous delivery orders, or original solicitation details are provided.

### Description

4571942326!CYKLOKAPRON 1,000 MG/10 ML VL 10ML

[View original record](https://www.usaspending.gov/award/CONT_AWD_SPE2D326F150H_9700_SPE2D020D0014_9700)
